Skip to main content
PepStack
Blutwerte · Marker

Calcium

Serum Calcium · Ca · Kalzium

ElektrolyteZeitabhängig
Einheit:
mmol/L
Abbreviation
Ca2+

Calcium test quantifies the total serum calcium, including ionized calcium, protein-bound calcium, and calcium complexed with anions.

Reference Ranges

Reference
2.12.6mmol/L
1.8
2.1
2.2
2.5
2.6
3
LowNormalHigh
Reference
Optimal
Critical
Unit · mmol/L

Reference ranges may vary slightly by age and sex; fasting status can affect levels.

Overview

Übersicht

Calcium (Ca2+), also known as serum calcium, is a vital electrolyte that plays a crucial role in numerous biological processes, including bone mineralization, neuromuscular function, and blood coagulation. It exists in the blood in three forms: ionized, bound to proteins (primarily albumin), and complexed with anions. Researchers have found that the ionized form is the most biologically active and tightly regulated by parathyroid hormone (PTH), vitamin D, and calcitonin. Clinically, calcium levels are significant in diagnosing and managing conditions such as hypoparathyroidism, hyperparathyroidism, osteoporosis, and renal disease. Elevated calcium levels, or hypercalcemia, can indicate primary hyperparathyroidism or malignancy, while low levels, or hypocalcemia, may result from hypoparathyroidism, vitamin D deficiency, or renal failure. For athletes and biohackers, maintaining optimal calcium levels is essential for bone health and muscle function, potentially impacting performance and recovery. However, researchers observed that calcium levels can be influenced by factors such as age, sex, and dietary intake, and may fluctuate based on time of day and fasting status. Therefore, accurate assessment requires standardized testing conditions, and interpretation should consider these confounding factors.

Klinische Bedeutung

Elevated calcium levels may indicate hyperparathyroidism, malignancy, or vitamin D intoxication. Reduced calcium levels can suggest hypoparathyroidism, vitamin D deficiency, or chronic kidney disease.

Dynamics

Trend Interpretation

Rising Values

Progressively rising calcium levels suggest possible hyperparathyroidism or malignancy. Re-test within 4 weeks if elevated.

Falling Values

Falling calcium levels may indicate worsening renal function or malabsorption issues.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Primary hyperparathyroidism
  • Malignancy
  • Vitamin D intoxication
  • Thiazide diuretics
  • Prolonged immobilization
Cause

Low Levels

  • Hypoparathyroidism
  • Vitamin D deficiency
  • Chronic kidney disease
  • Hypomagnesemia
  • Acute pancreatitis
Protocol

How to Optimize

Lever

Lifestyle

  • Regular weight-bearing exercise
  • Adequate sunlight exposure
  • Avoid excessive alcohol consumption
Lever

Nutrition

  • Consume calcium-rich foods like dairy
  • Include leafy greens
  • Ensure adequate protein intake
Lever

Supplementation

  • Calcium carbonate
  • Vitamin D
  • Magnesium

Note:

Consult a healthcare provider before starting supplements, especially if you have a history of kidney stones or hypercalcemia.

Testing Guidelines

Fasting Not Required
🕐Time-Sensitive

Calcium levels can vary throughout the day; morning samples may be more consistent.

Testing Frequency

Annually for healthy adults, more frequently if managing a related condition.

Interfering Factors

  • Recent intense exercise
  • High protein intake
  • Certain medications like lithium

Related Peptides & Hormones

hormone

Open Research Questions

Current research suggests that reference ranges for serum calcium may vary significantly based on demographic factors, and optimal targets for calcium levels in specific populations, such as those with hypoparathyroidism or osteoporosis, remain debated. Researchers have not yet established the long-term efficacy and safety of emerging therapies targeting calcium homeostasis. Additionally, clinical questions regarding the best monitoring strategies for calcium levels during pregnancy and lactation in patients with hypoparathyroidism remain unanswered.

21 Research Publications

242

Total Citations

3

Human/RCT

1.8

Avg. Influence

2025

Latest

Sort
Filter
#01

Ionized Calcium in the ICU: Should It Be Measured and Corrected?

ReviewInfluence3.0
70
Researchers discussed the measurement of ionized calcium in ICU patients, finding that many have abnormal levels. They observed that while measuring ionized calcium is common, its correction may not always be beneficial and could even be harmful in critical illness.
View on PubMed
#02

Hypocalcemia in the newborn.

ReviewInfluence2.0
61
This study examined hypocalcemia in newborns, noting that it is a common clinical issue. Researchers found that healthy term infants typically experience a physiological drop in calcium levels shortly after birth, while high-risk neonates may require calcium supplementation.
View on PubMed
#03

Management of Hypoparathyroidism.

ReviewInfluence3.0
46
This study examined the management of hypoparathyroidism, a condition characterized by low calcium levels. Researchers found that conventional therapy with calcium and vitamin D aims to maintain serum calcium levels but has limitations, including fluctuations and complications. They also noted that parathyroid hormone replacement may be considered when conventional therapy is unsatisfactory.
View on PubMed
#04

Clinical value of serum calcium in elderly patients with sepsis.

HumanInfluence1.0
19
This study explored the clinical significance of serum calcium levels in elderly patients with sepsis. Researchers found that lower serum calcium levels were associated with increased severity of sepsis and higher mortality rates. They also noted a negative correlation between serum calcium and procalcitonin levels.
View on PubMed
#05

Mechanosensitivity of microdomain calcium signalling in the heart.

ReviewInfluence1.0
17
Researchers examined calcium signaling in cardiac myocytes, noting its importance in heart function. They found that local calcium gradients are crucial for contraction and that dysregulation can lead to serious cardiac issues, highlighting the mechanosensitivity of calcium signaling.
View on PubMed
#06

The Laboratory and Clinical Perspectives of Magnesium Imbalance.

ReviewInfluence1.0
15
Researchers highlighted the significance of magnesium in relation to calcium homeostasis and its role in various bodily functions. The study pointed out that magnesium imbalance can coexist with other electrolyte disorders, affecting clinical outcomes.
View on PubMed
#07

Pathogenic roles of altered calcium channels and transporters in colon tumorogenesis.

Review
11
This review summarized the roles of calcium channels and transporters in colorectal cancer. Researchers observed that altered calcium signaling may contribute to tumorigenesis, suggesting that targeting calcium pathways could be a potential therapeutic strategy.
View on PubMed
#08

[Clinical significance of calcium sensitizer].

Review
3
This article reviewed the clinical significance of calcium sensitizers in heart failure treatment. Researchers found that while these agents were expected to improve outcomes, trials have not met expectations, indicating a need for better-targeted therapies.
View on PubMed
#09

[Hypocalcemia].

Review
This study defined hypocalcemia as a serum calcium level below the reference range and identified various causes, including vitamin D deficiency and renal insufficiency. Researchers noted that the management of hypocalcemia depends on its causes and severity.
View on PubMed
#10

[Hypocalcemia, emergency or not ?].

Review
This article reviewed hypocalcemia, defining it and discussing its clinical implications. Researchers found that prompt management is crucial to normalize serum calcium and address symptoms, emphasizing the need for a thorough understanding of calcium metabolism.
View on PubMed

Clinical Trials (16)

16

Total Trials

14,255

Total Enrolled

Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA)

NCT07551960ENROLLING_BY_INVITATION
Sponsor

Nemocnice AGEL Trinec-Podlesi a.s.

Enrollment

100

Started

2026

Primary outcome

Change in AGEL Gamification Index (AGI) from Baseline to 12 Months

Cardiovascular Risk FactorsInsulin ResistanceObesityDyslipidemiasMetabolic Syndrome

Effective Dosing of Burosumab in XLH

NCT07183579RECRUITING
Sponsor

University of Nottingham

Enrollment

120

Started

2025

Primary outcome

The proportion of patients who achieved biochemical control (serum phosphate above the lower limit of the local reference range) on a dose of less than 0.8 mg/kg per dose of Burosumab.

X-linked Hypophosphatemia (XLH)

Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation

NCT06558474RECRUITING
Sponsor

Cathreine BV

Enrollment

12,000

Started

2023

Primary outcome

Occurrence of target vessel revascularization, myocardial infarction and all-cause mortality

Coronary Artery Disease

Home-based Transcranial Direct Current Stimulation in Postpartum Depression: the Feasibility Study and Pilot Study

NCT05046405NOT_YET_RECRUITING
Sponsor

Ana Ganho Ávila

Enrollment

50

Started

2022

Primary outcome

Feasibility of the intervention - Number of completed tDCS applications

Postnatal Depression

Effect of Evolocumab on Coronary Plaque Characteristics

NCT04710368Phase 4COMPLETED
Sponsor

Annapoorna Kini

Enrollment

137

Started

2021

Primary outcome

Change in Minimal Fibrous Cap Thickness (FCT)

Coronary Artery Disease

Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

NCT04659603Phase 2TERMINATED
Sponsor

Sanofi

Enrollment

50

Started

2021

Primary outcome

Objective Response Rate (ORR)

Breast Cancer MetastaticPancreatic Carcinoma Metastatic

Acetazolamide Efficacy in Ataxia in PMM2-CDG

NCT04679389Phase 2/3TERMINATED
Sponsor

Mayo Clinic

Enrollment

25

Started

2021

Primary outcome

Efficacy of Acetazolamide on Ataxia Measured Via Miniature International Cooperative Ataxia Rating Scale (Mini-ICARS)

Pmm2-CDGCDG1A

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

NCT04164069Phase 1COMPLETED
Sponsor

Anne Noonan

Enrollment

9

Started

2020

Primary outcome

Recommended phase II dose (RP2D) of dasatinib

Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8Stage II Colon CancerStage II Rectal CancerStage III Colon CancerStage III Rectal CancerEsophageal CancerPancreatic CancerBile Duct CancerGastric CancerGall Bladder CancerSmall Bowel Adenocarcinoma

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

NCT03604627RECRUITING
Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Enrollment

500

Started

2018

Primary outcome

Incidence of a calcium score

Childhood Cancer

Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure

NCT03389386COMPLETED
Sponsor

Josko Bozic

Enrollment

120

Started

2018

Primary outcome

Catestatin levels in blood serum

Heart Failure,Congestive

Extragonadal Effects of hCG on Calcium Homeostasis

NCT03418896Phase 1COMPLETED
Sponsor

Martin Blomberg Jensen

Enrollment

12

Started

2018

Primary outcome

Serum calcium

HypogonadismCalcium DisorderRenal Disease

PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis

NCT05500989RECRUITING
Sponsor

Maastricht University Medical Center

Enrollment

226

Started

2016

Primary outcome

Relationship between placental acute atherosis and subclinical coronary atherosclerosis at 1 year postpartum

Pre-EclampsiaHELLP SyndromeIntrauterine Growth RestrictionPregnancy

Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol)

NCT01802658Phase 3TERMINATED
Sponsor

Nantes University Hospital

Enrollment

12

Started

2012

Primary outcome

determine DMO distal femur at 36 months

Bone Demineralization Lesions in the Injured Marrow

Ultrasound Imaging Technique in Detecting Breast Microcalcifications in Patients Undergoing Biopsy for a Breast Abnormality

NCT03031561COMPLETED
Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Enrollment

85

Started

2012

Primary outcome

Number of microcalcifications seen on MicroPure ultrasound

Breast CarcinomaMicrocalcification

Pulmonary Disease in Patients Referred for Coronary CT

NCT01734629COMPLETED
Sponsor

University of Sao Paulo General Hospital

Enrollment

205

Started

2011

Primary outcome

Coronary Calcium Score

Coronary Artery DiseaseAtherosclerosesCOPDRespiratory Diseases

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis

NCT00404820Phase 3COMPLETED
Sponsor

Novartis

Enrollment

604

Started

2006

Primary outcome

Change of Cross-linked N-telopeptide of Type I Collagen (NTx) Level Assessed as Standardized Area Under the Curve From Screening to Month 12 in the Intent-to-Treat Population

Osteoporosis

Publication Trend

Research publications about Calcium over time

5total
1
'98
1
'01
1
'07
1
'22
1
'23

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer